Article info

Download PDFPDF

Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial

Authors

  • Hamid Ahmadieh Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Ramin Nourinia Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Ali Hafezi-Moghadam Molecular Biomarkers Nono-Imaging Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hamideh Sabbaghi Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Shintaro Nakao Molecular Biomarkers Nono-Imaging Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan PubMed articlesGoogle scholar articles
  • Souska Zandi Molecular Biomarkers Nono-Imaging Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA Berner Augenklinik am Lindenhofspital, Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Mehdi Yaseri Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Zahra Tofighi Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Shadi Akbarian Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Hamid Ahmadieh, Ophthalmic Research Center, Labbafinejad Medical Center, Tehran 16666, Iran; hahmadieh{at}hotmail.com
View Full Text

Citation

Ahmadieh H, Nourinia R, Hafezi-Moghadam A, et al
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial

Publication history

  • Received March 13, 2018
  • Revised July 1, 2018
  • Accepted July 26, 2018
  • First published August 27, 2018.
Online issue publication 
June 21, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.